Different previously researches provided evidence of iNKT cells being quantitatively and qualitatively defective in MM, subsequently hampering their antitumour effects,33 and they observed that advanced stages of MM were associated with the progressive loss of the ability of iNKT cells to secrete IFN‐γ. The gene discussed is IFNG; the disease is Miyoshi myopathy.